LEADER 00892nam0-2200289 --450 
001 9910566992703321
005 20220531083828.0
010   $a9780128092170
100   $a20220530d2018----kmuy0itay5050    ba
101 0 $aeng
102   $aUS
105   $a        001yy
200 1 $aPost-authorization safety studies of medicinal products$ethe PASS book$fAyad K. Ali, Abraham G. Hartzema
210   $aSan Diego$cElsevier$d2018
215   $aXIV, 348 p.$d25 cm
610 0 $aFarmaci$aEpidemiologia
610 0 $aFarmacovigilanza
676   $a615.704$v23
700  1$aAli,$bAyad K.$01225290
701  1$aHartzema,$bAbraham G.$01225291
801  0$aIT$bUNINA$gREICAT$2UNIMARC
901   $aBK
912   $a9910566992703321
952   $a80 562/XXIV 120$bBFA562/2022$fFFABC
959   $aFFABC
996   $aPost-authorization safety studies of medicinal products$92844961
997   $aUNINA